The Republic of Iceland – Government Debt Management
| Series | RIKB 22 1026 | ||
| Settlement Date | 03/10/2021 | ||
| Total Amount Allocated (MM) | 5,400 | ||
| All Bids Awarded At (Price / Yield) | 109.250 | / | 1.460 |
| Total Number of Bids Received | 2 | ||
| Total Amount of All Bids Received (MM) | 5,400 | ||
| Total Number of Successful Bids | 2 | ||
| Number of Bids Allocated in Full | 2 | ||
| Lowest Price / Highest Yield Allocated | 109.250 | / | 1.460 |
| Highest Price / Lowest Yield Allocated | 109.250 | / | 1.460 |
| Lowest Price / Highest Yield Allocated in Full | 109.250 | / | 1.460 |
| Weighted Average of Successful Bids (Price/Yield) | 109.250 | / | 1.460 |
| Best Bid (Price / Yield) | 109.250 | / | 1.460 |
| Worst Bid (Price / Yield) | 109.250 | / | 1.460 |
| Weighted Average of All Bids Received (Price / Yield) | 109.250 | / | 1.460 |
| Percentage Partial Allocation (Approximate) | 100.00 % | ||
| Bid to Cover Ratio | 1.00 | ||
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Scatec ASA6.12.2025 08:00:00 CET | Press release
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
Junshi Biosciences6.12.2025 04:11:15 CET | Press release
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Zealand Pharma5.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
AlphaTON Capital5.12.2025 18:19:57 CET | Press release
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
Volta Finance Limited5.12.2025 18:17:40 CET | Press release
Dividend Declaration
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom